Vitamin D (Cholecalciferol) with Low Dose Vitamin C as a Safe and E ective Therapeutic Modality in an Adult with COVID-19 Pneumonia | [Journal of College of Physicians and Surgeons--Pakistan : JCPSP • 2021]

Author(s):

1. Shahan Waheed: Department of Emergency Medicine, Aga Khan University Hospital,Karachi,Pakistan

2. Rana Osama Zahid: Department of Emergency Medicine, Aga Khan University Hospital,Karachi,Pakistan

3. Summaiya Tauseeq Khan: Department of Emergency Medicine, Aga Khan University Hospital,Karachi,Pakistan

4. Faysal Subhani: Department of Emergency Medicine, Aga Khan University Hospital,Karachi,Pakistan

5. Emaduddin Siddiqui: Department of Emergency Medicine, Aga Khan University Hospital,Karachi,Pakistan

Abstract:

This is a case of an elderly female presenting with fever, cough and shortness of breath. On presentation, she had tachypnea and an oxygen requirement of 2 liters through nasal prongs. Her investigations were suggestive of COVID-19 pneumonia with bilateral ground-glass appearance on chest X-ray and a positive nasopharyngeal PCR swab. She had low vitamin D levels on presentation and was given 200,000 units of cholecalciferol, once daily for 3 days with Vitamin C, 500 mg per oral once daily for 7 days. Her symptoms got progressively better and her oxygen requirement diminished on next day. On day 3, her symptoms completely resolved, and her chest X-ray improved. In patients with COVID-19 pneumonia, who are vitamin D de cient, administration of large doses of cholecalciferol for few days can be a safe option to treat mild to moderate COVID-19 pneumonia.

Page(s): 0-2

DOI: DOI not available

Published: Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 31, Issue: S2, Year: 2021

Keywords:

vitamin C , pneumonia , COVID19 , Vitamin D

References:

References are not available for this document.

Citations

Citations are not available for this document.

Citations

Downloads

Views